A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Vericel Corp stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 7,925 shares of VCEL stock, worth $453,785. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,925
Previous 10,900 27.29%
Holding current value
$453,785
Previous $500 Million 33.05%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $125,693 - $159,341
-2,975 Reduced 27.29%
7,925 $335 Million
Q2 2024

Aug 15, 2024

SELL
$41.71 - $52.9 $58,936 - $74,747
-1,413 Reduced 11.48%
10,900 $500 Million
Q1 2024

May 07, 2024

SELL
$32.52 - $52.33 $584,026 - $939,794
-17,959 Reduced 59.33%
12,313 $641 Million
Q4 2023

Feb 14, 2024

BUY
$30.85 - $37.09 $933,891 - $1.12 Million
30,272 New
30,272 $1.08 Billion

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Susquehanna Portfolio Strategies, LLC Portfolio

Follow Susquehanna Portfolio Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Portfolio Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Portfolio Strategies, LLC with notifications on news.